GLP1R and type 2 diabetes mellitus: On the other hand, a recent meta-analysis focusing on the effect of GLP-1 RAs on prognosis in patients with HF showed that GLP-1 RAs significantly reduced the risk of MACE compared to placebo in HF coexisting with T2DM.